Monthly costs for GLP-1 medications in Canada could drop from up to $400 to as low as $15 once generic competition enters the market, according to industry analysts tracking the pharmaceutical transition
Lets break down what the research says about the average percentage of body weight people can expect to lose at 3 months, 6 months, and beyond
Ongoing Monitoring Schedule Starting GLP-1 therapy is the beginning of a monitoring relationship, not a one-time event
Do not stop semaglutide or tirzepatide without consulting your healthcare provider, as abrupt discontinuation can cause rapid weight regain and metabolic rebound
Each batch is carefully tested to verify identity, purity, and stability , ensuring it meets the quality standards required for scientific investigation
The UK SmPC for Wegovy includes a warning about these findings but does not list a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) as formal contraindications, unlike in some other jurisdictions